Playing Music to Cells to Unlock the Industrial Potential of Advanced Therapeutics

GET CONNECTED
kolibrilab.com

Team

Amélie Quilichini

CEO & Co-Founder

Gabriel Dumy

CSO & Co-Founder

Kolibri

Company details

Kolibri revolutionizes the way we grow cells at scale using acoustic waves. Showing 100x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies – or in the cellular agriculture space more broadly.

Female FoundersHuman HealthFranceSeedHard TechHealthcareHuman HealthTherapeuticsIndieBio NY 06

Get In Touch with Kolibri

Please tell us a little bit about yourself and why you'd like to get connected. Kolibri + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More